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INTRODUCTION

OUTCOMES

•	Omnipaque contrast dye is used for visualization in patients undergoing
transcatheter aortic valve replacement (TAVR)

RESULTS
•	Patients with pre-existing kidney issues:
			 −	there was no statistical significance showing the patients who were given more dye
had greater changes in pre to post procedural creatinine levels (p=0.5732).

356 TAVR patients
studied

•	Dye may impinge on the patient’s kidney health

•	Patients with no pre-existing kidney issues:

•	A previous study reported a wide range of 15% to 57% of the TAVR patients
1
developed acute kidney injury after the TAVR procedure

			 −	there was no statistical significance showing that patients who were given more
dye were more likely to develop a kidney disease post-TAVR (p=0.3190).
262 with no kidney
issues

61 with pre-existing
kidney issues

33 developed kidney
issues post-procedure

OBJECTIVE
12 with kidney issues
within 30 days of TAVR

•	This study seeks to assess the creatinine level of patients over time and
analyze the effects of the TAVR procedure on kidney function

•	Patients who developed a kidney issue:
			 −	there was no statistical significance showing the patients who were given more dye
were more likely to develop a kidney disease within 30 days of the TAVR procedure
(p=0.8122).

21 with kidney issues
in more than 30 days
post-TAVR

CONCLUSIONS

Figure 1: Flowchart Categorizing Kidney Issues in TAVR Patients.

METHODS

Creatinine Changes When
Administered < 100cc Dye

Creatinine Changes When
Administered > 100cc Dye

• This was a retrospective single-center observational study
• Included 356 patients with severe aortic stenosis who underwent the TAVR procedure between
Classified
January 2015 – June 2017 at Lehigh Valley Health Network

Reviewed

Analyzed
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• Electronic medical records were used to assess patient creatinine levels before and after
surgery and record the amount of contrast dye used in the TAVR procedure

• Descriptive statistics were used to evaluate the relationship between kidney function and the
TAVR procedure

•	This was a negative study, revealing no statistical significance that Ominpaque
contrast dye injections correlate to post-TAVR kidney issues
•	Although there is always some risk that patients develop chronic kidney disease
or acute kidney injury from the procedure, the results suggest that the cardiac
team should not deny patients as TAVR candidates because of the possible
complications from using contrast dye
•	Further research is recommended to assess the effects of other contrast dyes on
kidney function and to extend the study to other tertiary hospitals.
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Figure 2: Box Plot of Changes in Creatinine Levels Based on the Concentration of Contrast Dye Administered.
The box plots sh ow the absolute value changes in creatinine levels from the pre-TAVR workup to
the 2 days post-TAVR labs.

